Amlodipine/celecoxib

Last updated

Amlodipine/celecoxib
Combination of
Amlodipine Calcium channel blocker
Celecoxib Nonsteroidal anti-inflammatory drug (NSAID)
Clinical data
Trade names Consensi
AHFS/Drugs.com Monograph
License data
Routes of
administration 		By mouth
ATC code
Legal status
Legal status
Identifiers
KEGG

Amlodipine/celecoxib, sold under the brand name Consensi, is a fixed-dose combination medication used to treat both hypertension and osteoarthritis at the same time in adults. [1] [2] It contains amlodipine, as the besylate, and celecoxib. [1] It is taken by mouth. [1]

Contents

The most common side effects include edema, abdominal pain, diarrhea, dyspepsia, flatulence, peripheral edema, accidental injury, dizziness, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, and rash. [1]

It was approved for medical use in the United States in May 2018. [3]

Medical uses

Amlodipine/celecoxib is indicated for use in adults for whom treatment with amlodipine for hypertension and celecoxib for osteoarthritis are appropriate. [1]

History

Amlodipine/celecoxib was approved for use in the United States in May 2018. [3]

References

  1. 1 2 3 4 5 6 "Consensi- amlodipine besylate and celecoxib tablet". DailyMed. 17 December 2019. Retrieved 14 May 2020.
  2. ↑ Smith SM, Cooper-DeHoff RM (February 2019). "Fixed-Dose Combination Amlodipine/Celecoxib (Consensi) for Hypertension and Osteoarthritis". The American Journal of Medicine. 132 (2): 172–174. doi:10.1016/j.amjmed.2018.08.027. PMID   30240679. S2CID   52312672.
  3. 1 2 "Drug Approval Package: Consensi (amlodipine and celecoxib)". U.S. Food and Drug Administration (FDA). 29 November 2018. Retrieved 14 May 2020.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.